Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This study is a phase 1 study of PF-06651600. PF-06651600 is being developed for treatment of inflammatory bowel disease. The goal of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06651600 after multiple oral doses of PF-06651600 in Japanese healthy volunteers.
Epistemonikos ID: b45ad8ebabc0afbf6171d342c2fc61a5e2a1a160
First added on: May 21, 2024